US 7071205
5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds
granted A61PA61P15/00A61P15/08
Quick answer
US patent 7071205 (5-cycloalkenyl 5H-chromeno[3,4-f]quinoline derivatives as selective progesterone receptor modulator compounds) held by Ligand Pharmaceuticals Incorporated expires Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ligand Pharmaceuticals Incorporated
- Grant date
- Tue Jul 04 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61P, A61P15/00, A61P15/08, A61P15/12, A61P15/18